<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>AML | Matthew A. Clarke</title>
    <link>https://mclarke1991.github.io/tag/aml/</link>
      <atom:link href="https://mclarke1991.github.io/tag/aml/index.xml" rel="self" type="application/rss+xml" />
    <description>AML</description>
    <generator>Wowchemy (https://wowchemy.com)</generator><language>en-us</language><lastBuildDate>Mon, 03 Oct 2022 10:39:44 +0000</lastBuildDate>
    <image>
      <url>https://mclarke1991.github.io/media/icon_hu0b7a4cb9992c9ac0e91bd28ffd38dd00_9727_512x512_fill_lanczos_center_3.png</url>
      <title>AML</title>
      <link>https://mclarke1991.github.io/tag/aml/</link>
    </image>
    
    <item>
      <title>HOXA9 has the hallmarks of a biological switch with implications in blood cancers</title>
      <link>https://mclarke1991.github.io/publication/talarmain2022/</link>
      <pubDate>Mon, 03 Oct 2022 10:39:44 +0000</pubDate>
      <guid>https://mclarke1991.github.io/publication/talarmain2022/</guid>
      <description>&lt;p&gt;Image credit: Adapted from &lt;a href=&#34;https://www.nature.com/articles/s41467-022-33189-w&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Talarmain et al., &lt;em&gt;Nat Comm&lt;/em&gt;, 2022&lt;/a&gt;.  &lt;a href=&#34;https://creativecommons.org/licenses/by/4.0/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;CC-BY 4.0&lt;/a&gt;&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>Prognostic hallmarks in AML</title>
      <link>https://mclarke1991.github.io/publication/clarke2019a_prognostichallmarks/</link>
      <pubDate>Fri, 08 Nov 2019 14:40:12 +0000</pubDate>
      <guid>https://mclarke1991.github.io/publication/clarke2019a_prognostichallmarks/</guid>
      <description></description>
    </item>
    
  </channel>
</rss>
